Senior insider sale
Chief Operating Officer at BICYCLE THERAPEUTICS PLC — senior position signals high conviction
$64.7K
8.88K shares
What this filing means
MILNES ALISTAIR plans to sell 8.88K shares of BICYCLE THERAPEUTICS PLC valued at approximately $64.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/2/2026ACC: 0001972481-26-000008
Officer· Chief Operating Officer
Since Jan 2022
8.88K
Shares to sell
$64.7K
Approx. market value
13.22K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Restricted Stock Units
Equity Compensation
1/3/2026
2.03KRestricted Stock Units
Equity Compensation
1/2/2026
11.19KTotal acquired13.22K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2026 | Restricted Stock Units Equity Compensation | 2.03K | — |
1/2/2026 | Restricted Stock Units Equity Compensation | 11.19K | — |
| Total | 13.22K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
978.00
Market value
$8.2K
10/3/2025
—Completed
Units to sell
1.15K
Market value
$9.6K
7/3/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
6.75K
Market value
$46.9K
1/2/2026
Total
Units
8.88K
Value
$64.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/3/2025 | 978.00 | $8.2K | — | Completed |
7/3/2025 | 1.15K | $9.6K | — | Completed |
| Planned — Approximate Date | ||||
1/2/2026 | 6.75K | $46.9K | Nasdaq | Planned |
| Total | 8.88K | $64.7K | ||